BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishina, S.
Right arrow Articles by Azuma, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishina, S.
Right arrow Articles by Azuma, N.
Br J Ophthalmol 1999;83:723-727 ( June )

PAX6 expression in the developing human eye

Sachiko Nishinaa, Shinichi Kohsakab, Yuki Yamaguchic, Hiroshi Handac, Atsushi Kawakamid, Hajime Fujisawad, Noriyuki Azumaa

a Department of Ophthalmology, National Children's Hospital, Tokyo, Japan, b Department of Neurochemistry, National Institute of Neuroscience, Tokyo, Japan, c Department of Biomolecular Engineering, Faculty of Bioscience and Biotechnology, Tokyo Institute of Technology, Kanagawa, Japan, d Division of Biological Science, Nagoya University Graduate School of Science, Nagoya, Japan

Correspondence to: Noriyuki Azuma, MD, Department of Ophthalmology, National Children's Hospital, 3-35-31 Taishido, Setagaya-ku, Tokyo, 154-8509, Japan.

Accepted for publication 11 January 1999

AIMS---To investigate the changes in PAX6 expression in the developing human eye.
METHODS---Six developing human eyes from 6 to 22 weeks' gestation were evaluated. Frozen sections were immunohistochemically stained with monoclonal antibody to chick Pax6 (amino acids 1-223). To verify antibody specificity, western blot analysis was carried out using cell lysates from P19 cells transfected with the human PAX6 gene.
RESULTS---Western blot analysis demonstrated that the antibody reacted to human PAX6 protein. Positive immunostainings for PAX6 were seen in the surface ectoderm, lens vesicle, inner and outer layers of the optic cup, and optic stalk at 6 weeks, and in the corneal epithelia and conjunctiva, lens, and non-pigmented ciliary epithelia from 8 to 22 weeks. In the retina, positive cells were seen in the entire retina from 8 to 10 weeks, and were restricted to the ganglion cell layer and the inner and outer portions of the inner nuclear layer after 21 weeks.
CONCLUSIONS---PAX6 is expressed on the surface and neuroectoderms at an early stage, then in the differentiating cells in the cornea, lens, ciliary body, and retina through development. PAX6 may play a role in determining cell fate in the morphogenesis of various human ocular tissue.


© 1999 by British Journal of Ophthalmology



This article has been cited by other articles:


Home page
IOVSHome page
H. C. Turner, M. T. Budak, M. A. M. Akinci, and J. M. Wolosin
Comparative Analysis of Human Conjunctival and Corneal Epithelial Gene Expression with Oligonucleotide Microarrays
Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2050 - 2061.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. Xu, D. D. Sta. Iglesia, J. L. Kielczewski, D. F. Valenta, M. E. Pease, D. J. Zack, and H. A. Quigley
Characteristics of Progenitor Cells Derived from Adult Ciliary Body in Mouse, Rat, and Human Eyes
Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1674 - 1682.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
L. Feng, X. Xie, P. S. Joshi, Z. Yang, K. Shibasaki, R. L. Chow, and L. Gan
Requirement for Bhlhb5 in the specification of amacrine and cone bipolar subtypes in mouse retina
Development, December 15, 2006; 133(24): 4815 - 4825.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
P. McGannon, Y. Miyazaki, P. C. Gupta, E. I. Traboulsi, and C. Colmenares
Ocular Abnormalities in Mice Lacking the Ski Proto-oncogene.
Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4231 - 4237.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
N. Davis-Silberman, T. Kalich, V. Oron-Karni, T. Marquardt, M. Kroeber, E. R. Tamm, and R. Ashery-Padan
Genetic dissection of Pax6 dosage requirements in the developing mouse eye
Hum. Mol. Genet., August 1, 2005; 14(15): 2265 - 2276.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
N. Azuma, K. Tadokoro, A. Asaka, M. Yamada, Y. Yamaguchi, H. Handa, S. Matsushima, T. Watanabe, S. Kohsaka, Y. Kida, et al.
The Pax6 isoform bearing an alternative spliced exon promotes the development of the neural retinal structure
Hum. Mol. Genet., March 15, 2005; 14(6): 735 - 745.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. E. Ploski, M. K. Shamsher, and A. Radu
Paired-Type Homeodomain Transcription Factors Are Imported into the Nucleus by Karyopherin 13
Mol. Cell. Biol., June 1, 2004; 24(11): 4824 - 4834.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
T. Inoue, M. Hojo, Y. Bessho, Y. Tano, J. E. Lee, and R. Kageyama
Math3 and NeuroD regulate amacrine cell fate specification in the retina
Development, March 4, 2003; 129(4): 831 - 842.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
E. Heon, A. Greenberg, K. K. Kopp, D. Rootman, A. L. Vincent, G. Billingsley, M. Priston, K. M. Dorval, R. L. Chow, R. R. McInnes, et al.
VSX1: A gene for posterior polymorphous dystrophy and keratoconus
Hum. Mol. Genet., May 1, 2002; 11(9): 1029 - 1036.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Duncan, Z Kozmik, K Cveklova, J Piatigorsky, and A Cvekl
Overexpression of PAX6(5a) in lens fiber cells results in cataract and upregulation of (alpha)5(beta)1 integrin expression
J. Cell Sci., January 9, 2000; 113(18): 3173 - 3185.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1999 by the BMJ Publishing Group Ltd.